5-fluorodopa has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuriakose, R; Stoessl, AJ | 1 |
| Consales, A; Garrè, ML; Morana, G; Nozza, P; Piccardo, A; Rossi, A | 1 |
1 review(s) available for 5-fluorodopa and Disease Exacerbation
| Article | Year |
|---|---|
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Topics: Animals; Biomarkers; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Humans; Magnetic Resonance Imaging; Movement Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Synapses; Tomography, Emission-Computed, Single-Photon | 2010 |
1 other study(ies) available for 5-fluorodopa and Disease Exacerbation
| Article | Year |
|---|---|
Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treate
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Child, Preschool; Dacarbazine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Ganglioglioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Temozolomide | 2013 |